NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks ofU. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 5.67% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.54% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.50% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.98% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 4.97% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.88% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 4.63% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.11% |
| PCRX | Pacira BioSciences, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 4.04% |
| LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 3.98% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 3.40% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.35% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.17% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 3.07% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.00% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.97% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 2.87% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 2.76% |